Employment and work disability in systemic lupus erythematosus: A systematic review

Rheumatology

Volumn 48, Issue 3, 2009, Pages 281-284

  Baker, Kim ^a   Pope, Janet ^b,c  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c NONE   (Canada)

Author keywords

Employment; Systemic lupus erythematosus; Work disability

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANXIETY; ARTICLE; COCHRANE LIBRARY; COGNITIVE DEFECT; CONTROLLED STUDY; COST OF ILLNESS; DISEASE ACTIVITY; DISEASE DURATION; EDUCATIONAL STATUS; EMBASE; EMPLOYMENT; FATIGUE; GENETIC HETEROGENEITY; HUMAN; LITERATURE; MAJOR CLINICAL STUDY; MEDLINE; PAIN; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SAMPLING; SOCIAL ASPECT; SOCIOECONOMICS; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; UNEMPLOYMENT; WORK DISABILITY;

ADULT; AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; EMPLOYMENT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOCIAL CLASS;

EID: 61349119464     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken477     Document Type: Article

References (33)

1. Merkel PA. Systemic lupus erythematosus. In: Andreoli TE, Carpenter CCJ, Ivor BJ, eds. Cecil essentials of medicine, 6th Edition. Philadelphia: Elsevier, 2004;745.
2. Bertoli AM, Fernandez M, Alarcon GS, Vila LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): Factors predictive of selfreported work disability. Ann Rheum Dis 2007;66:12-7.
3. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue. Measurement of fatigue in systemic lupus erythematosus: A systematic review. Arthritis Rheum 2007;57:1348-57.
4. Da Costa D, Dobkin PL, Pinard L et al. The role of stress in functional disability among women with systemic lupus erythematosus: A prospective study. Arthritis Care Res 1999;12:112-9.
5. Yelin E, Trupin L, Katz P et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:56-63.
6. Panopalis P, Petri M, Manzi S et al. the Tri-Nation Study Group. The systemic lupus erythematosus Tri-Nation study: Cumulative indirect costs. Arthritis Rheum 2007;57:64-70.
7. Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005;32:721-8.
8. Clarke AE, Penrod J, St, Pierre Y et al. Underestimating the value of women: Assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group. J Rheumatol 2000;27:2597-604.
9. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993;36:1548-59.
10. Nived O, Andersson M, Lindgren M et al. Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaire. Lupus 2007;16:701-6.
11. Utset TO, Fink J, Doninger NA. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 2006;33:531-8.
12. Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Tervaert JW. Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: A comparison with Wegener's granulomatosis. Arthritis Rheum 2002;47:196-201.
13. Partridge AJ, Karlson EW, Daltroy LH et al. Risk factors for early work disability in systemic lupus erythematosus: Results from a multicenter study. Arthritis Rheum 1997;40:2199-206.
14. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum 2008;59:136-43.
15. Huang HC, Chou CT, Lin KC, Chao YF. The relationships between disability level, health-promoting lifestyle, and quality of life in outpatients with systemic lupus erythematosus. J Nurs Res 2007;15:21-32.
16. Jönsson G, Sjöholm AG, Truedsson L, Bengtsson AA, Braconier JH, Sturfelt G. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency. Rheumatology 2007;46:1133-9.
17. Stamm TA, Bauernfeind B, Coenen M et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum 2007;57:1287-95.
18. Sundaramurthy S, Bush TM, Neuwelt CM, Ward MM. Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosus. Lupus 2003;12:443-8.
19. Ward MM, Sundaramurthy S, Lotstein D, Bush TM, Neuwelt CM, Street RL Jr. Participatory patient-physician communication and morbidity in patients with systemic lupus erythematosus. Arthritis Rheum 2003;49:810-8.
20. Jönsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: Increased morbidity but low mortality. Rheumatology 2002;41:1308-12.
21. Tench C, Bentley D, Vleck V, McCurdie I, White P, D'Cruz D. Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol 2002;29:474-81.
22. Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology 2001;40:37-47.
23. Lotstein DS, Ward MM, Bush TM, Lambert RE, van Vollenhoven R, Neuwelt CM. Socioeconomic status and health in women with systemic lupus erythematosus. J Rheumatol 1998;25:1720-9.
24. Murphy NG, Koolvisoot A, Schumacher HR, Von Feldt JM, Callegari PE. Musculoskeletal features in systemic lupus erythematosus and their relationship with disability. J Clin Rheumatol 1998;4:238-45.
25. Lacaille D, Clarke AE, Bloch DA, Danoff D, Esdaile JM. The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus. J Rheumatol 1994;21:448-53.
26. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994;37:1181-8.
27. Hochberg MC, Sutton JD. Physical disability and psychosocial dysfunction in systemic lupus erythematosus. J Rheumatol 1988;15:959-64.
28. Benitha R, Tikly M. Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2007;26:24-9.
29. Agresti A, Coull BA. Approximate is better than 'exact' for interval estimation of binomial proportions. Am Stat 1998;52:119-26.
30. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927;22:209-12.
31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
32. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
33. Lacaille D. Arthritis and employment research: Where are we? Where do we need to go? J Rheumatol 2005;32(Suppl. 72):42-5.